Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 67, Issue 6, Pages 1347-1353Publisher
OXFORD UNIV PRESS
DOI: 10.1093/jac/dks061
Keywords
multidrug resistance; extended-spectrum -lactamases; ESBLs; AmpC
Funding
- Indian Council of Medical Research (ICMR), New Delhi, India [5/8-1(218)-D/2007 ECD-II]
Ask authors/readers for more resources
To determine the pattern and antimicrobial resistance genes of cephalosporin resistance in Shigella flexneri and Shigella dysenteriae over 9 years. Isolates of Shigella (S. flexneri, n119 and S. dysenteriae, n24) were tested for resistance to ceftriaxone and cefepime by disc diffusion, for MIC by Etest and for extended-spectrum -lactamase (ESBL) and AmpC production. The presence of antimicrobial resistance genes was investigated by PCR using specific primers for bla(TEM), bla(OXA-1), bla(CTX-M-15), bla(SHV) and bla(CMY-2) for all the isolates. Twenty (16.8) S. flexneri isolates were resistant/intermediately susceptible to ceftriaxone/cefepime, while all S. dysenteriae were susceptible. In S. flexneri isolates, the MIC50 values of ceftriaxone and cefepime were found to be 0.032 and 0.125 mg/L, respectively, while their MIC90 values were 12 and 8 mg/L, respectively. The MIC50 and MIC90 for S. dysenteriae were below 1 mg/L for ceftriaxone; however, for cefepime the MIC90 was found to be 4 mg/L. Of the 20 resistant/intermediately susceptible S. flexneri isolates, 9 were positive for ESBL production and 4 for AmpC production by phenotypic tests. All 20 isolates were found to be positive for bla(TEM), 10 for bla(CTX-M-15), 8 for bla(OXA) and 7 for bla(CMY-2); none was positive for bla(SHV). We report a high level of cephalosporin resistance with high MICs and ESBL- and AmpC-mediated antibiotic resistance in Shigella from north India.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available